Safety and efficacy of double plasma molecular adsorption system with sequential low‐volume plasma exchange in intermediate‐stage hepatitis B virus‐related acute‐on‐chronic liver failure
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28650 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Wenxiong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, End Stage Liver Disease, Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Current evidence suggests that the mortality rate of intermediate‐stage hepatitis B virus (HBV)‐related acute‐on‐chronic liver failure (ACLF) remains high. We aimed to investigate the safety and efficacy of double plasma molecular adsorption system (DPMAS) with sequential low‐volume plasma exchange (LPE) treatment in intermediate‐stage HBV‐related ACLF. This prospective study recruited intermediate‐stage HBV‐related ACLF patients and was registered on ClinicalTrials.gov (NCT 04597164). Eligible patients were randomly divided into a trial group and a control group. Patients in both groups received comprehensive medical treatment. Patients in the trial group further received DPMAS with sequential LPE. Data were recorded from baseline to Week 12. Fifty patients with intermediate‐stage HBV‐related ACLF were included in this study. The incidence of bleeding events and allergic reactions in the trial group was 12% and 4%, respectively, with no other treatment‐related adverse events. The levels of total bilirubin and prothrombin time‐international normalized ratio, and model for end‐stage liver disease scores after each session of DPMAS with sequential LPE were significantly lower than those before treatment (all p < 0.05). The 12‐week cumulative liver transplantation‐free survival rates in the trial and control groups were 52% and 24%, respectively ( p = 0.041). The 12‐week cumulative overall survival rates in the trial and control groups were 64% and 36%, respectively ( p = 0.048). The Kaplan–Meier survival analysis revealed significant differences in liver transplantation‐free survival ( p = 0.047) and overall survival ( p = 0.038) between the trial and control groups. Cox regression analysis indicated that blood urea nitrogen ( p = 0.038), DPMAS with sequential LPE ( p = 0.048), and Chinese Group on the Study of Severe Hepatitis B‐ACLF II score ( p < 0.001) were significant risk factors for mortality. DPMAS with sequential LPE treatment is safe and effective for patients with intermediate‐stage HBV‐related ACLF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Liang Peng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, W., Zhu, S., Yang, L., Li, Z., Wu, L., Zhang, Y., Chen, J., Deng, Z., Luo, Q., & Peng, L. (2023). Safety and efficacy of double plasma molecular adsorption system with sequential low‐volume plasma exchange in intermediate‐stage hepatitis B virus‐related acute‐on‐chronic liver failure. Journal of Medical Virology. https://doi.org/10.1002/jmv.28650
Vancouver
Xu W, Zhu S, Yang L, Li Z, Wu L, Zhang Y, et al. Safety and efficacy of double plasma molecular adsorption system with sequential low‐volume plasma exchange in intermediate‐stage hepatitis B virus‐related acute‐on‐chronic liver failure. Journal of Medical Virology. 2023. doi:10.1002/jmv.28650
BibTeX
@article{Xu2023,
author = {Xu, Wenxiong and Zhu, Shu and Yang, Luo and Li, Zhipeng and Wu, Lina and Zhang, Yeqiong and Chen, Jia and Deng, Zhexuan and Luo, Qiumin and Peng, Liang},
title = {Safety and efficacy of double plasma molecular adsorption system with sequential low‐volume plasma exchange in intermediate‐stage hepatitis B virus‐related acute‐on‐chronic liver failure},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28650}
}
EUVIMED